Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. Tait-Kamradt, T. Davies, P.C. Appelbaum, F. Depardieu, P. Courvalin, J. Petitpas.
Two mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.
Antimicrob Agents Chemother, 44 (2000), pp. 3395-3401
[2.]
F. Depardieu, P. Courvalin.
Mutation in 23S rRna responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.
Antimicrob Agents Chemother, 45 (2001), pp. 319-323
[3.]
J. Jalava, J. Kataja, H. Seppälä, P. Huovinen.
In vitro activities of the novel ketolide telithromycin (Hmr 3647) against erythromycin-resistant Streptococcus species.
Antimicrob Agents Chemother, 45 (2001), pp. 789-793
[4.]
V. Perreten, F.V. Schwarz, M. Teuber, S.B. Levy.
Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli.
Antimicrob Agents Chemother, 45 (2001), pp. 1109-1114
[5.]
A. Mazzariol, Y. Tokue, T.M. Kanegawa, G. Cornaglia, H. Nikaido.
High-level fluoroquinolone-resistant isolates of Escherichia coli overproduce multidrug efflux protein AcrA.
Antimicrob Agents Chemother, 44 (2000), pp. 3441-3443
[6.]
M. Oethinger, W.V. Kern, A.S. Jellen-Ritter, L.M. McMurry, S.B. Levy.
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistant in Escherichia coli in the abscense of the AcrAB efflux pump.
Antimicrob Agents Chemother, 44 (2000), pp. 10-13
[7.]
E. Giraud, A. Cloeckaert, D. Kerbouf, E. Chaslus-Dancla.
Evidence for active efflux pump as the primary mechanisms of resistance to ciprofloxacin in Salmonella enterica Serovar Typhimurium.
Antimicrob Agents Chemother, 44 (2000), pp. 1223-1228
[8.]
L.J.V. Piddock, D.G. White, K. Gensberg, Pumbwe, D.J. Griggs.
Evidence for an Efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium.
Antimicrob Agents Chemother, 44 (2000), pp. 3118-3121
[9.]
M.N. Alekshum, S.B. Levy.
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon.
Antimicrob Agents Chemother, 41 (1997), pp. 2067-2075
[10.]
J.H. Chou, J.T. Greenberg, B. Demple.
Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense Rna by the soxRS locus.
J Bacteriol, 175 (1993), pp. 1026-1031
[11.]
P.J. Pomposiello, B. Demple.
Identification of SoxS-regulated genes in Salmonella enterica serovar Typhimurium.
J Bacteriol, 182 (2000), pp. 23-29
[12.]
T.M. Barbosa, S.B. Levy.
Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA.
J Bacteriol, 182 (2000), pp. 3467-3474
[13.]
A. Koutsolioutsou, E.A. Martins, D.G. White, S.B. Levy, B. Demple.
A soxRS constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (serovar Typhimurium).
Antimicrob Agents Chemother, 45 (2001), pp. 38-43
[14.]
A. Alonso, J.L. Martínez.
Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia.
Antimicrob Agents Chemother, 44 (2000), pp. 3079-3086
[15.]
R. Bonnet, J.L.M. Sampaio, C. Chanal, D. Sirot, C. De Champs, J.L. Viallard.
A novel class A extended spectrum β-lactamase (Bes-1) in Serratia marcescens isolated in Brazil.
Antimicrob Agents Chemother, 44 (2000), pp. 3061-3068
[16.]
R. Bonnet, J.L.M. Sampaio, R. Labia, C. De Champs, D. Sirot, C. Chanal.
A novel CTX-M β-lactamase (Ctx-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.
Antimicrob Agents Chemother, 44 (2000), pp. 1936-1942
[17.]
M. Sabate, R. Tarrago, F. Navarro, E. Miro, C. Verges, J. Barre.
Cloning and sequence of the gene encoding a novel cefotaxime-hidrolizing β-lactamase (Ctx-M-9) from Escherichia coli in Spain.
Antimicrob Agents Chemother, 44 (2000), pp. 1970-1973
[18.]
A. Oliver, J.C. Pérez-Díaz, T.M. Coque, F. Baquero, R. Cantón.
Nucleotide sequence and characterization of a novel cefotaxime-hidrolizing β-lactamase (CTX-M-10) isolated in Spain.
Antimicrob Agents Chemother, 45 (2001), pp. 616-620
[19.]
M. Yuan, L.M.C. Hall, P.H.M. Savelkoul, C. Vandenbroucke-Grauls, D.M. Livermore.
Shv-13, a novel extended spectrum β-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.
Antimicrob Agents Chemother, 44 (2000), pp. 1081-1084
[20.]
J.J. Yan, S.M. Wu, S.H. Tsai, J.J. Wu, I.J. Su.
Prevalence of Shv-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan.
Antimicrob Agents Chemother, 44 (2000), pp. 1438-1442
[21.]
J. Fiett, A. Palucha, B. Miacynska, M. Stankiewicz, H.P. Mordarska, W. Hryniewicz.
A novel complex mutant β-lactamase, TEM-8, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum β-lactamase-producing klebsiellae.
Antimicrob Agents Chemother, 44 (2000), pp. 1499-1505
[22.]
H. Kurokawa, T. Yagi, N. Shibata, K. Shibayama, K. Kamachi, Y. Arakawa.
A new SHV-derived extended-spectrum β-lactamase (SHV-24) that hydrolizes ceftazidime through a single-amino-acid substitution (D179G) in the Ω-loop.
Antimicrob Agents Chemother, 44 (2000), pp. 1725-1727
[23.]
J. Silva, C. Aguilar, G. Ayala, M.A. Estrada, U. Garza-Ramos, R. Lara-Lemus.
Tla-1: a new plasmid-mediated extended-spectrum β-lactamase, from Escherichia coli.
Antimicrob Agents Chemother, 44 (2000), pp. 997-1003
[24.]
L. Poirel, I. Le Thomas, T. Naas, A. Karim, P. Nordmann.
Biochemical sequence analyses of Ges-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.
Antimicrob Agents Chemother, 44 (2000), pp. 622-632
[25.]
P. Giakkoupi, L.S. Tzouvelekis, A. Tsakris, V. Loukova, D. Sofianou, E. Tzelepi.
Ibc-1, a novel integron-associated Class A β -lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.
Antimicrob Agents Chemother, 44 (2000), pp. 2247-2253
[26.]
J.C. Galán, M. Reig, A. Navas, F. Baquero, J. Blázquez.
Aci-1 from Acidaminococcus fermentans: Characterization of the first β-lactamase in aerobic cocci.
Antimicrob Agents Chemother, 44 (2000), pp. 3144-3149
[27.]
N. Woodford, M.F.I. Palepou, G.S. Sabini, B. Holmes, D.M. Livermore.
Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: distribution of blaB and characterization of a novel metallo-β-lactamasa gene, blaB3, in the type strain, Ntcc 10016.
Antimicrob Agents Chemother, 44 (2000), pp. 1448-1452
[28.]
L. Boschi, S.M. Mercuri, M.L. Riccio, G. Amicosante, M. Galleni, J.M. Frère.
The Legionella (Fluoribacter) gormanii metallo-β-lactamase: a new member of the highly divergent lineage of molecular-subclass B3-β-lactamases.
Antimicrob Agents Chemother, 44 (2000), pp. 1538-1543
[29.]
L. Poirel, T. Naas, D. Nicolas, L. Collet, S. Bellais, J.D. Cavallo.
Characterization of Vim-2, a carbapenem-hydrolizing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
Antimicrob Agents Chemother, 44 (2000), pp. 891-897
[30.]
H. Yano, A. Kuga, R. Okamoto, H. Kitasato, T. Kobayashi, M. Inoue.
Plasmidencoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.
Antimicrob Agents Chemother, 45 (2001), pp. 1343-1348
[31.]
H.M. Donald, W. Scaife, S.G.B. Amyes, H.K. Young.
Sequence analysis of ARI-1, a novel OXA β -lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.
Antimicrob Agents Chemother, 44 (2000), pp. 196-199
[32.]
G. Bou, A. Oliver, J. Martínez-Beltrán.
OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.
Antimicrob Agents Chemother, 44 (2000), pp. 1556-1561
[33.]
M. Afzal-Shah, N. Woodford, D.M. Livermore.
Characterization of OXA-25, OXA-26, and OXA-27, molecular class D-β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.
Antimicrob Agents Chemother, 45 (2001), pp. 583-588
[34.]
A.M. Queenan, C. Torres-Viera, H.S. Gold, Y. Carmeli, G.M. Eliopoulos, R.C. Moellering Jr.
SME-type carbapenem-hydrolyzing class A β-lactamases from geographically diverse Serratia marcescens strains.
Antimicrob Agents Chemother, 44 (2000), pp. 3035-3039
[35.]
H. Yigit, A.M. Queenan, G.J. Anderson, A. Domenech-Sanchez, J.W. Biddle, C.D. Steward.
Novel carbapenem-hydrolizing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
Antimicrob Agents Chemother, 45 (2001), pp. 1151-1161
[36.]
V. Simonet, M. Mallêa, J.M. Pagès.
Substitutions in the eyelet region disrupt cefepime diffusion through the Escherichia coli OmpF channel.
Antimicrob Agents Chemother, 44 (2000), pp. 311-315
[37.]
L.B. Rice, L.L. Carias, A.M. Hujer, M. Bonafede, R. Hutton, C. Hoyen.
High-level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
Antimicrob Agents Chemother, 44 (2000), pp. 362-367
[38.]
L. Martínez-Martínez, A. Pascual, S. Hernández-Allés, D. Álvarez-Díaz, A.I. Suárez, J. Tran.
Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.
Antimicrob Agents Chemother, 43 (1999), pp. 1669-1673
[39.]
S.J. McKessar, A.M. Berry, J.M. Bell, J.D. Turnidge, J.C. Paton.
Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis.
Antimicrob Agents Chemother, 44 (2000), pp. 3224-3228
[40.]
L.M.D. Costa, P.E. Reynolds, H. Souza, D.C. Souza, M.F.I. Papelou, N. Woodford.
Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil.
Antimicrob Agents Chemother, 44 (2000), pp. 3444-3446
[41.]
S. Boyle-Vavra, H. Labischinsky, C.C. Ebert, K. Ehlert, R.S. Daum.
A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates.
Antimicrob Agents Chemother, 45 (2001), pp. 280-287
[42.]
B. Aracil, M. Miñambres, J. Oteo, J.L. Gómez-Garcés, J.I. Alós.
High prevalence of erythromycin-resistant and clindamycin-susceptible (M-phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria.
J Antimicrob Chemother, 48 (2001), pp. 592-594
[43.]
M.J. Ferrándiz, A. Fenoll, J. Liñares, A. De La Campa.
Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.
Antimicrob Agents Chemother, 44 (2000), pp. 840-847
[44.]
K.P. Scott, C.M. Melville, T.M. Barbosa, H.J. Flint.
Ocurrence of the new tetracycline resistance gene tet(W) in bacteria from the human gut.
Antimicrob Agents Chemother, 44 (2000), pp. 775-777
[45.]
A. Seoane, J.M. García Lobo.
Identification of a streptogramina A acetyltransferase gene in the chromosome of Yersinia enterocolitica.
Antimicrob Agents Chemother, 44 (2000), pp. 905-909
[46.]
V.A. Luna, S. Cousin Jr, W.L.H. Whittington, M.C. Roberts.
Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates.
Antimicrob Agents Chemother, 44 (2000), pp. 2503-2506
[47.]
T.P. Stinear, C.O. Olden, P.D.R. Johnson, J.K. Davies, M.L. Grayson.
Enterococcal vanB resistance locus in anaerobic bacteria in human faeces.
Lancet, 357 (2001), pp. 855-856
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
